143 related articles for article (PubMed ID: 19276142)
1. Severe hiccups during chemotherapy: corticosteroids the likely culprit.
Gilbar P; McPherson I
J Oncol Pharm Pract; 2009 Dec; 15(4):233-6. PubMed ID: 19276142
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-related hiccups: male predominance, induction by dexamethasone, and protection against nausea and vomiting.
Liaw CC; Wang CH; Chang HK; Wang HM; Huang JS; Lin YC; Chen JS
J Pain Symptom Manage; 2005 Oct; 30(4):359-66. PubMed ID: 16256900
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid rotation to alleviate dexamethasone-induced hiccup: a case series at a single institution.
Kang JH; Hui D; Kim MJ; Kim HG; Kang MH; Lee GW; Bruera E
J Pain Symptom Manage; 2012 Mar; 43(3):625-30. PubMed ID: 21924583
[TBL] [Abstract][Full Text] [Related]
4. Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
Gao HF; Liang Y; Zhou NN; Zhang DS; Wu HY
Intern Med J; 2013 Jan; 43(1):73-6. PubMed ID: 22141732
[TBL] [Abstract][Full Text] [Related]
5. Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial.
Nishimura J; Satoh T; Fukunaga M; Takemoto H; Nakata K; Ide Y; Fukuzaki T; Kudo T; Miyake Y; Yasui M; Morita S; Sakai D; Uemura M; Hata T; Takemasa I; Mizushima T; Ohno Y; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M;
Eur J Cancer; 2015 Jul; 51(10):1274-82. PubMed ID: 25922233
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with dexamethasone-induced hiccups in cancer patients undergoing chemotherapy: A case control study.
Kim J; Oh H; Seo W
Eur J Oncol Nurs; 2018 Dec; 37():23-28. PubMed ID: 30473047
[TBL] [Abstract][Full Text] [Related]
8. Use of vinegar to relieve persistent hiccups in an advanced cancer patient.
Gonella S; Gonella F
J Palliat Med; 2015 May; 18(5):467-70. PubMed ID: 25775370
[TBL] [Abstract][Full Text] [Related]
9. [5-Fluorouracil-induced reticular hyperpigmentation].
Sanz-Sánchez T; Córdoba S; Jiménez-Ayala B; Borbujo JM
Actas Dermosifiliogr; 2008 Sep; 99(7):573-4. PubMed ID: 18682175
[No Abstract] [Full Text] [Related]
10. [The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL)].
Chauffert B; Bonnotte B; Chvetzoff G; Flesch M
Presse Med; 1998 May; 27(18):859. PubMed ID: 9767871
[No Abstract] [Full Text] [Related]
11. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.
Rapoport B; Schwartzberg L; Chasen M; Powers D; Arora S; Navari R; Schnadig I
Eur J Cancer; 2016 Apr; 57():23-30. PubMed ID: 26851398
[TBL] [Abstract][Full Text] [Related]
13. Analysis of factors associated with hiccups based on the Japanese Adverse Drug Event Report database.
Hosoya R; Uesawa Y; Ishii-Nozawa R; Kagaya H
PLoS One; 2017; 12(2):e0172057. PubMed ID: 28196104
[TBL] [Abstract][Full Text] [Related]
14. Treatment of dexamethasone-induced hiccup in chemotherapy patients by methylprednisolone rotation.
Lee GW; Oh SY; Kang MH; Kang JH; Park SH; Hwang IG; Yi SY; Choi YJ; Ji JH; Lee HY; Bruera E
Oncologist; 2013; 18(11):1229-34. PubMed ID: 24107973
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of exhausting hiccup in a patient treated with chemotherapy for metastatic colon cancer.
Errante D; Bernardi D; Bianco A; Zanatta N; Salvagno L
Gut; 2005 Oct; 54(10):1503-4. PubMed ID: 16162960
[No Abstract] [Full Text] [Related]
16. Antiemetic effectiveness and nausea and vomiting incidence during capecitabine and oxaliplatin chemotherapy.
Chan A; Tan SH; Low XH; Yap KY
Nurs Res; 2012; 61(6):405-12. PubMed ID: 22960588
[TBL] [Abstract][Full Text] [Related]
17. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
[TBL] [Abstract][Full Text] [Related]
18. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
19. Management of diabetes and pancreatic cancer.
Flaherty AM
Oncol Nurs Forum; 2012 Sep; 39(5):440-3. PubMed ID: 22940508
[No Abstract] [Full Text] [Related]
20. Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant.
Grote T; Hajdenberg J; Cartmell A; Ferguson S; Ginkel A; Charu V
J Support Oncol; 2006 Sep; 4(8):403-8. PubMed ID: 17004515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
